Glioblastoma

This is a very aggressive type of brain cancer. It starts in the brain tissue and can grow quickly, often causing symptoms like seizures or problems with movement or speech.

Condition

What people with Glioblastoma report

Every report comes from a Lived member, sent anonymously.

Have you tried Temozolomide for Glioblastoma?

NameHow it went

About Glioblastoma

What It Is

Glioblastoma is the most common cancerous brain tumor that begins in the brain itself in adults. It grows from glial cells, the supporting cells that surround and protect nerve cells, and it is the fastest-growing type of glioma (grade 4 on the World Health Organization scale). Rather than forming a neat lump, it sends microscopic strands of tumor into the surrounding brain. That is why it cannot be fully removed with surgery and why it tends to come back after treatment. Symptoms depend on where the tumor sits and how quickly it grows. Headache is common, sometimes worse in the morning or accompanied by nausea and vomiting as pressure builds inside the skull. Other people first notice a seizure, weakness on one side of the body, trouble finding words, changes in vision, or shifts in personality, attention or judgment that family members may see before the person does. These changes usually develop over weeks to a few months. Glioblastoma is different from cancer that starts elsewhere, such as in the lung, and spreads to the brain. That is called brain metastasis and is treated differently. Glioblastoma itself rarely spreads outside the brain and spinal cord.

Causes & Risk Factors

For most people, no cause can be identified. Glioblastoma becomes more common after age 40, and rates are highest in people in their late 70s and early 80s. It is somewhat more common in men than in women. The one well-established outside risk factor is earlier radiation to the head, usually given years before to treat another cancer, often in childhood. Only a small minority of adults with a malignant brain tumor have a family history of brain tumors or an inherited cancer syndrome, such as Li-Fraumeni syndrome or neurofibromatosis type 1. Good-quality studies have not shown that cell phone use causes brain tumors. Because most cases have no known cause, a diagnosis does not reflect something the person did wrong.

How It's Diagnosed

Evaluation usually starts with a neurological exam, which checks strength, reflexes, coordination, vision, speech and thinking. The key imaging test is magnetic resonance imaging (MRI) of the brain taken before and after an injected contrast dye (gadolinium). Glioblastoma typically appears as a ring-shaped area that lights up with the dye, with a dead center and swelling in the brain around it. A computed tomography (CT) scan is sometimes done first, particularly in an emergency setting. Imaging strongly suggests the diagnosis but cannot confirm it. A pathologist must examine tumor tissue, which is obtained during surgery to remove the tumor or, when the tumor cannot be removed safely, through a needle biopsy. The tissue is also tested for genetic features that shape treatment and outlook. One test looks for a change in the IDH gene. Similar-looking tumors that carry this change are classified separately as IDH-mutant astrocytomas, which usually affect younger adults and respond better to treatment; glioblastoma, as currently defined, has no IDH change. The lab also checks the MGMT gene. When this gene is switched off (reported as "methylated"), the tumor is more likely to respond to temozolomide chemotherapy, and survival tends to be longer. Because glioblastoma rarely spreads beyond the brain, scans of the rest of the body are generally not needed.

Treatment Options

Treatment aims to control the tumor for as long as possible while protecting the person's abilities and quality of life. It is usually planned by a team that includes a neurosurgeon, a radiation oncologist and a neuro-oncologist, ideally at a center experienced in treating brain tumors. There is currently no cure, but treatment can lengthen life and relieve symptoms. The first step is usually surgery to remove as much tumor as can be taken out safely. Surgeons put preserving movement, speech and other functions first, and some operations are done with the patient awake so these abilities can be checked as the surgeon works. Removing all of the visible tumor is linked with longer survival, but microscopic tumor cells always remain, so further treatment follows. About three to six weeks after surgery, the standard next step is six weeks of weekday radiation combined with temozolomide (Temodar), an oral chemotherapy capsule taken daily during radiation. After a four-week break, temozolomide resumes for five days of every 28-day cycle, typically for six cycles. In the trial that set this standard, adding temozolomide raised the share of people alive at two years from about 11% to 27%. The benefit is largest when the MGMT gene is methylated. Because temozolomide can lower blood counts, blood tests are done before each cycle. For older or frailer adults, a shorter three-week course of radiation with temozolomide is an evidence-based option. Some people receive radiation alone or temozolomide alone, depending on their overall health and MGMT result. Tumor treating fields are a further option after radiation is finished. A portable device delivers low-intensity electrical fields through adhesive pads on the shaved scalp and is worn at least 18 hours a day. In a large trial, adding it to temozolomide lengthened survival by several months, though wearing it nearly all the time is a real commitment. When glioblastoma returns, options include another operation, a second course of radiation, other chemotherapy such as lomustine, and bevacizumab (Avastin), an infused drug that blocks the blood-vessel growth tumors rely on. Bevacizumab can reduce swelling and ease symptoms, but it has not been shown to help people live longer, either at diagnosis or when the tumor returns. Because standard options are limited, specialists encourage people to consider a clinical trial, both at diagnosis and at recurrence. Supportive treatment is a large part of care. Dexamethasone, a steroid, reduces swelling around the tumor and the symptoms it causes, but longer use can bring muscle weakness and a higher risk of certain infections, so doctors aim for the lowest dose that works and taper it when they can. It should not be stopped suddenly without the care team's guidance. Anti-seizure medicines such as levetiracetam (Keppra) are used for people who have had a seizure; they are not routinely given to people who have never had one.

What to Expect

Glioblastoma is a serious diagnosis. Treatment can extend life and ease symptoms, but it rarely cures the disease, and the tumor almost always grows back, often within the first year. With current standard treatment, median survival (the point by which half of people have died) is about 12 to 21 months, and about 7 in 100 people live five years or longer. On average, outlook is better for younger people, people who are able to stay active and independent, people whose tumor could be largely removed, and people with a methylated MGMT gene. These are averages, and individual courses vary widely. The first months revolve around treatment: recovering from surgery, daily radiation visits on weekdays, and regular blood tests. Fatigue is common. Some people live with lasting changes in strength, speech, memory, concentration or mood, and these can shift over time as the tumor and its treatment affect the brain. Depression is common and worth raising, because it can be treated. Blood clots in the legs or lungs are more common in people with brain tumors, especially in the weeks after surgery. Regular MRI scans after treatment check whether the tumor is growing again, and results guide whether to continue, change or stop treatment. Palliative care, which focuses on comfort, symptoms and planning, works alongside cancer treatment and is worth involving early rather than only near the end of life. Talking early about goals, work, finances and who will make medical decisions if the person cannot lets them take part while they are able. Fertility preservation is worth discussing before treatment for people who may want children, and because temozolomide can harm a pregnancy, both women and men need reliable contraception during treatment and for several months after it ends. Caregivers often carry a heavy load and benefit from support of their own.

When to Seek Help

See a doctor about headaches that are new and persistent, especially morning headaches with nausea or vomiting, or about changes in speech, vision, balance, strength, memory or personality that build over days or weeks. A first seizure in an adult needs same-day medical evaluation, usually in an emergency department. For someone already diagnosed, call the care team right away about new or worsening headache, weakness, confusion, mild or gradually increasing sleepiness, speech problems, a new seizure or seizures becoming more frequent, which can signal swelling or tumor growth. During chemotherapy, call right away for a fever of 100.5°F (38°C) or higher or chills, since temozolomide can lower the white blood cells that fight infection. Call promptly, too, about pain or swelling in one leg, which can be a blood clot. Call 911 if the person becomes very hard to wake or unresponsive, or has a sudden, severe worsening of headache with vomiting and confusion, which can mean dangerous pressure building inside the skull. Call 911, too, for a seizure that lasts more than five minutes, repeated seizures without waking up in between, or sudden shortness of breath or chest pain, which can mean a blood clot has reached the lungs.

Questions to Ask Your Doctor

  1. 1.What did the tumor testing show, including IDH and MGMT, and how do those results change my treatment or outlook?
  2. 2.How much of the tumor could be removed safely, and what are the risks to my speech, movement or thinking?
  3. 3.What are the realistic benefits and trade-offs of each treatment option for someone with my age and health?
  4. 4.Are there clinical trials I should consider now, before treatment choices narrow my eligibility?
  5. 5.Who on the team can help with symptoms, rehabilitation, palliative care and planning for my family?

Last reviewed • Oct 2026

Educational content, not medical advice.